SRF LTD. - 503806 - Commissioning And Capitalisation Of Capital Expenditure Proposal Approved By The Board
This is in continuation of our letter dated 25th January, 2022 informing Board's approval for a project to create Pharma Intermediates Plant for undertaking precursor processes for production of Pharma products at Dahej. It is hereby informed that project has been commissioned and capitalized on 12th April, 2023 at an aggregate cost of Rs. 223 Crores (approx.).12-04-2023